Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity
- PMID: 22973190
- PMCID: PMC3434418
- DOI: 10.3389/fnmol.2012.00091
Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity
Abstract
Corticotropin releasing factor (CRF) has been shown to induce various behavioral changes related to adaptation to stress. Dysregulation of the CRF system at any point can lead to a variety of psychiatric disorders, including substance use disorders (SUDs). CRF has been associated with stress-induced drug reinforcement. Extensive literature has identified CRF to play an important role in the molecular mechanisms that lead to an increase in susceptibility that precipitates relapse to SUDs. The CRF system has a heterogeneous role in SUDs. It enhances the acute effects of drugs of abuse and is also responsible for the potentiation of drug-induced neuroplasticity evoked during the withdrawal period. We present in this review the brain regions and circuitries where CRF is expressed and may participate in stress-induced drug abuse. Finally, we attempt to evaluate the role of modulating the CRF system as a possible therapeutic strategy for treating the dysregulation of emotional behaviors that result from the acute positive reinforcement of substances of abuse as well as the negative reinforcement produced by withdrawal.
Keywords: addiction; anxiety; corticotropin releasing factor system; ethanol; neuroplasticity; stress-induced.
Similar articles
-
Stress, corticotropin-releasing factor, and drug addiction.Ann N Y Acad Sci. 1999;897:27-45. doi: 10.1111/j.1749-6632.1999.tb07876.x. Ann N Y Acad Sci. 1999. PMID: 10676433 Review.
-
Corticotropin-Releasing Factor (CRF) and Addictive Behaviors.Int Rev Neurobiol. 2017;136:5-51. doi: 10.1016/bs.irn.2017.06.004. Epub 2017 Aug 7. Int Rev Neurobiol. 2017. PMID: 29056155 Free PMC article. Review.
-
Neurobiological substrates for the dark side of compulsivity in addiction.Neuropharmacology. 2009;56 Suppl 1(Suppl 1):18-31. doi: 10.1016/j.neuropharm.2008.07.043. Epub 2008 Aug 7. Neuropharmacology. 2009. PMID: 18725236 Free PMC article. Review.
-
Corticotropin releasing factor and neuroplasticity in cocaine addiction.Life Sci. 2010 Jan 2;86(1-2):1-9. doi: 10.1016/j.lfs.2009.11.005. Epub 2009 Nov 13. Life Sci. 2010. PMID: 19914260 Review.
-
Neurocircuitry of alcohol addiction: synthesis from animal models.Handb Clin Neurol. 2014;125:33-54. doi: 10.1016/B978-0-444-62619-6.00003-3. Handb Clin Neurol. 2014. PMID: 25307567 Review.
Cited by
-
Cross-talk between the HPA axis and addiction-related regions in stressful situations.Heliyon. 2023 Apr 17;9(4):e15525. doi: 10.1016/j.heliyon.2023.e15525. eCollection 2023 Apr. Heliyon. 2023. PMID: 37151697 Free PMC article. Review.
-
Sex Differences in the Subcellular Distribution of Corticotropin-Releasing Factor Receptor 1 in the Rat Hippocampus following Chronic Immobilization Stress.Neuroscience. 2018 Jul 15;383:98-113. doi: 10.1016/j.neuroscience.2018.05.007. Epub 2018 May 26. Neuroscience. 2018. PMID: 29753863 Free PMC article.
-
Mitochondria-Related Nuclear Gene Expression in the Nucleus Accumbens and Blood Mitochondrial Copy Number After Developmental Fentanyl Exposure in Adolescent Male and Female C57BL/6 Mice.Front Psychiatry. 2021 Nov 18;12:737389. doi: 10.3389/fpsyt.2021.737389. eCollection 2021. Front Psychiatry. 2021. PMID: 34867530 Free PMC article.
-
CP-154,526 Modifies CREB Phosphorylation and Thioredoxin-1 Expression in the Dentate Gyrus following Morphine-Induced Conditioned Place Preference.PLoS One. 2015 Aug 27;10(8):e0136164. doi: 10.1371/journal.pone.0136164. eCollection 2015. PLoS One. 2015. PMID: 26313266 Free PMC article.
-
Development and use of a high-throughput screen to identify novel modulators of the corticotropin releasing factor binding protein.SLAS Discov. 2022 Dec;27(8):448-459. doi: 10.1016/j.slasd.2022.09.005. Epub 2022 Oct 7. SLAS Discov. 2022. PMID: 36210051 Free PMC article.
References
-
- Baldwin H. A., Rassnick S., Rivier J., Koob G. F., Britton K. T. (1991). CRF antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat. Psychopharmacology (Berl.) 103, 227–232 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources